Reportlinker Adds Global Coronary Stents Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016
NEW YORK, June 21 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:
Global Coronary Stents Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016
Global Coronary Stents Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016
Summary
GlobalData's medical equipment report, "Global Coronary Stents Equipment Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016" provides key data, information and analysis on the global coronary stents market, a key segment within cardiovascular devices. The report provides market landscape, competitive landscape and market trends information the coronary stents market. The report provides comprehensive information on the key trends affecting the market, and key analytical content on the market dynamics. The report also reviews the competitive landscape, key pipeline products and technology offerings.
This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.
Scope
- Key geographies covered include the US (United States), Canada, the UK (United Kingdom), Germany, France, Italy, Spain, Japan, China, India, Australia, and Brazil.
- Key segments covered include Bare Metal Stents (BMS) and Drug Eluting Stents (DES).
- Annualized market revenues data from 2002 to 2009, forecast forward for 7 years to 2016. Company shares data for 2008.
- Qualitative analysis of key market trends, market drivers, and restraints by each category within the coronary stents market.
- The report also covers information on the leading market players, the competitive landscape, and the leading pipeline products and technologies.
- Key players covered include Cordis, Boston Scientific Corporation, Medtronic and Abbott.
Reasons to buy
- Develop business strategies by understanding the trends and developments that are driving the coronary stents market globally.
- Design and develop your product development, marketing and sales strategies.
- Exploit M&A opportunities by identifying market players with the most innovative pipeline.
- Develop market-entry and market expansion strategies.
- Identify key players best positioned to take advantage of the emerging market opportunities.
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return.
- What's the next being thing in the coronary stents market landscape? – Identify, understand and capitalize.
- Make more informed business decisions from the insightful and in-depth analysis of the global coronary stents market and the factors shaping it.
1 Table of contents 3
1.1 List of Tables 6
1.2 List of Figures 8
2 Introduction: Coronary Stents 9
2.1 GlobalData Report Guidance 9
3 Disease Overview: Coronary Heart Disease (CHD) 10
3.1 Pathophysiology 11
3.2 Signs and Symptoms 12
3.3 Risk Factor 12
3.3.1 Major Risk Factors that can't be Altered 12
3.3.2 Major Risk Factors that can be Altered 12
3.3.3 Other Risk Factors 13
3.4 Diagnosis 13
3.4.1 Electrocardiogram (ECG or EKG): 13
3.4.2 Exercise thallium test: 13
3.4.3 Echocardiography: 13
3.4.4 Coronary angiography: 13
3.4.5 Positron Emission Tomography (PET scanning): 13
3.5 Treatment 14
3.5.1 Coronary Heart Disease Epidemiology 14
3.5.2 Treatment modalities for CHD 16
4 Global Coronary Stents Market Characterization 18
4.1 Global Coronary Stents Market, Revenues ($bn), Historic, 2002 – 2009 18
4.2 Global Coronary Stents Market, Revenues ($bn), Forecast, 2009 – 2016 19
4.3 Global Coronary Stents, Market Dynamics 20
4.3.1 Coronary Stents: Market Drivers 20
4.3.2 Coronary Stents: Market Restraints 22
5 Global Coronary Stents Market: Segment Analysis 24
5.1 Bare Metal Stents, Global, Revenue ($bn), Historic, 2002– 2009 24
5.1.1 Bare Metal Stents, Global, Revenue ($bn), Forecast, 2009– 2016 25
5.2 Global Bare Metal Stents: Market Dynamics 26
5.2.1 Bare Metal Stents: Market Drivers 26
5.2.2 Bare Metal Stents: Market Restraints 26
5.2.3 Drug Eluting Stents, Global, Revenue ($bn), Historic, 2002– 2009 27
5.2.4 Drug Eluting Stents, Global, Revenue ($bn), Forecast, 2009– 2016. 28
5.3 Global Drug Eluting Stents:Market Dynamics 28
5.3.1 Drug Eluting Stents: Market Drivers 28
5.3.2 Drug Eluting Stents: Market Restraints 29
6 The Global Coronary Stents Market: Cross Country Analysis and Forecasts 30
6.1 Revenue and Revenue Forecast, By Country 31
6.1.1 US Coronary Stents market, Revenue ($ m), Historic, 2002-2009 31
6.1.2 US Coronary Stents market, Revenue ($ m), Forecast, 2009-2016 32
6.1.3 Canada Coronary Stents market, Revenue ($ m), Historic, 2002-2009 33
6.1.4 Canada, Coronary Stents market, Revenue ($ m), Forecast, 2002-2009 34
6.1.5 UK Coronary Stents market, Revenue ($ m), Historic, 2002-2009 35
6.1.6 UK Coronary Stents market, Revenue ($ m), Forecast, 2009-2016 36
6.1.7 Italy, Coronary Stents market, Revenue ($ m), Historic, 2002-2009 37
6.1.8 Germany, Coronary Stents market, Revenue ($ m), Historic, 2002-2009 39
6.1.9 Germany, Coronary Stents market, Revenue ($ m), Forecast, 2009-2016 40
6.1.10 France, Coronary Stents market, Revenue ($ m), Historic, 2002-2009 41
6.1.11 France, Coronary Stents market, Revenue ($ m), Forecast, 2009-2016 42
6.1.12 Spain, Coronary Stents market, Revenue ($ m), Historic, 2002-2009 43
6.1.13 Spain, Coronary Stents market, Revenue ($ m), Forecast, 2009-2016 44
6.1.14 Japan, Coronary Stents market, Revenue ($ m), Historic, 2002-2009 45
6.1.15 Japan, Coronary Stents market, Revenue ($ m), Forecast, 2009-2016 46
6.1.16 China, Coronary Stents market, Revenue ($ m), Historic, 2002-2009 47
6.1.17 China, Coronary Stents market, Revenue ($ m), Forecast, 2009-2016 48
6.1.18 India, Coronary Stents market, Revenue ($ m), Historic, 2002-2009 49
6.1.19 India, Coronary Stents market, Revenue ($ m), Forecast, 2009-2016 50
6.1.20 Brazil, Coronary Stents market, Revenue ($ m), Historic, 2002-2009 51
6.1.21 Brazil, Coronary Stents market, Revenue ($ m), Forecast, 2009-2016 52
6.1.22 Australia, Coronary Stents market, Revenue ($ m), Historic, 2002-2009 53
6.1.23 Australia, Coronary Stents market, Revenue ($ m), Forecast, 2009-2016 54
7 Global Coronary Stents Market: Strategic Competitive Assessment 55
7.1 Boston Scientific Corporation 57
7.1.1 Overview: 57
7.2 Cordis Corporation 58
7.2.1 Overview 58
7.3 Abbott Laboratories 59
7.3.1 Overview 59
7.4 Medtronic, Inc. 60
7.4.1 Overview 60
8 Global coronary Stents Market, Key Marketed products 62
8.1 Key Coronary Stents in the Market 62
8.1.1 CYPHER sirolimus-eluting coronary stents (JNJ Cordis) 62
8.1.2 PROMUS (Boston Scientific) 65
8.1.3 ENDEAVOR (Medtronic) 68
8.1.4 TAXUS Express2 (Boston Scientific) 71
8.1.5 TAXUS Liberte (Boston Scientific) 73
8.1.6 TriMaxx Coronary Stent (Abbott) 75
8.1.7 MULTI-LINK FRONTIER Coronary Bifurcation Stent System (Abbott) 75
9 Global Coronary Stents Market: Strategic Pipeline Assessment 76
9.1 Pipeline Technology Assessment 76
9.1.1 Pipeline Technology Assessment for Coronary Stents by Development Stage, Global 76
9.1.2 Emerging Technologies in the Coronary Stent Market 79
9.2 Profiles of Promising Products Under Clinical Development: 80
9.2.1 BioMatrix Drug Eluting Stent (Biosensors) 80
9.2.2 NEVO Sirolimus-eluting Coronary Stent (Cordis) 82
9.2.3 PROTEX Coronary Stent System (Nexeon MedSystems) 85
9.2.4 Valecor Platinum Coronary Stent System (CorNova) 85
9.2.5 GTX Coronary Stent System (Cook Medical) 86
9.2.6 JST Drug-Eluting Stent (Japan Stent Technology) 87
9.2.7 ProGenic Pimecrolimus-eluting Coronary Stent System (BIOTRONIK SE & Co. KG) 87
9.2.8 MAHOROBA (KANEKA CORPORATION) 88
9.2.9 ProLink LP (Vascular Concepts Limited) 89
9.2.10 ChromoFlex Coronary Stent (DISA Vascular) 90
9.2.11 Next generation everolimus-based stent (Boston Scientific) 91
9.2.12 ProNova Sirolimus Eluting Stent (Vascular Concepts Limited) 91
9.2.13 Coroflex DEBlue (B. Braun Melsungen AG) 92
9.2.14 Endeavor Resolute (Medtronic) 94
9.2.15 XIENCE NANO (Abbott Vascular) 96
9.2.16 TAXUS Petal Bifurcation Paclitaxel-Eluting Stent System (Boston Scientific) 96
9.2.17 CYPHER Max (4.0) (RX) (Cordis Corporation) 99
9.3 Coronary Stents:List of Pipeline Products 99
10 Global Coronary Stents Market: Key Companies with Products in Clinical Development 106
10.1.1 Biosensors International Group, Ltd. 106
10.1.2 Cook Medical Incorporated 106
10.1.3 OrbusNeich 107
10.1.4 Vascular Concepts Limited 108
10.1.5 CorNova, Inc. 108
10.1.6 Nexeon MedSystems, Inc. 109
11 Global Coronary Stents Market: Strategic Deals Analysis 110
11.1 Key Acquisitions 110
11.1.1 Medtronic Completes Acquisition Of Invatec And Affiliated Companies 111
11.1.2 Boston Scientific Acquires Labcoat 111
11.1.3 Bayer MaterialScience Completes Acquisition Of PolyBioMed From Lombard Medical Technologies 111
12 Appendix 113
12.1 Definitions 113
12.1.1 Coronary Stents 113
12.2 Acronyms 113
12.3 Research Methodology 114
12.4 Secondary Research 115
12.5 Primary Research 115
12.6 Models 116
12.7 Forecasts 116
12.8 Expert Panels 116
12.9 GlobalData Consulting 117
12.10 Contact Us 117
12.11 Disclaimer 117
1.1 List of Tables
Table 1: Coronary Stents Market, Global, Revenue ($bn), 2002 – 2009 18
Table 2: Coronary Stents Market, Global, Revenue ($bn), 2009 – 2016 19
Table 3: Bare Metal Stents, Global, Revenue ($bn), 2002– 2009 24
Table 4: Bare Metal Stents, Global, Revenue ($bn), 2009–2016 25
Table 5: Drug Eluting Stents Market, Global, Revenue ($bn), 2002– 2009 27
Table 6: Drug Eluting Stents, Global, Revenue ($bn), 2009– 2016 28
Table 7: Coronary Stents Market, Cross Country Analysis, Revenue ($m) and CAGR (%), 2002-2016 30
Table 8: Coronary Stents Market, US, Revenue ($ m), 2002-2009 31
Table 9: Coronary Stents Market, US, Revenue ($ m), 2009-2016 32
Table 10:Coronary Stents Market, Canada, Revenue ($ m), 2002-2009 33
Table 11:Coronary Stents Market, Canada, Revenue ($ m), 2009-2016 34
Table 12: Coronary Stents Market, UK, Revenue ($ m), 2002-2009 35
Table 13: Coronary Stents Market, UK, Revenue ($ m), 2009-2016 36
Table 14: Coronary Stents Market, Italy, Revenue ($ m), 2002-2009 37
Table 15: Coronary Stents Market, Italy, Revenue ($ m), 2009-2016 38
Table 16: Coronary Stents Market, Germany, Revenue ($ m), 2002-2009 39
Table 17: Coronary Stents Market, Germany, Revenue ($ m), 2009-2016 40
Table 18: Coronary Stents Market, France, Revenue ($ m), 2002-2009 41
Table 19: Coronary Stents Market, France, Revenue ($ m), 2009-2016 42
Table 20: Coronary Stents Market, Spain, Revenue ($ m), 2002-2009 43
Table 21: Coronary Stents Market, Spain, Revenue ($ m), 2009-2016 44
Table 22: Coronary Stents Market, Japan, Revenue ($ m), 2002-2009 45
Table 23: Coronary Stents Market, Japan, Revenue ($ m), 2009-2016 46
Table 24: Coronary Stents Market,China, Revenue ($ m), 2002-2009 47
Table 25: Coronary Stents Market,China, Revenue ($ m), 2009-2016 48
Table 26: Coronary Stents Market, India, Revenue ($ m), 2002-2009 49
Table 27: Coronary Stents Market, India, Revenue ($ m), 2009-2016 50
Table 28: Coronary Stents Market, Brazil, Revenue ($ m), 2002-2009 51
Table 29: Coronary Stents Market, Brazil, Revenue ($ m), 2009-2016 52
Table 30: Coronary Stents Market, Australia, Revenue ($ m), 2002-2009 53
Table 31: Coronary Stents Market, Australia, Revenue ($ m), 2009-2016 54
Table 32: Drug Eluting Stents Market , Global, Company Shares Revenue ($m), 2009 55
Table 33: Bare Metal Stents Market, Global, Company Shares Revenue ($m), 2009 56
Table 34: Boston Scientific Corporation, Coronary Stents, Pipeline Products 58
Table 35: Cordis, Coronary Stents, Pipeline Products 59
Table 36: Abbott Coronary Stents Pipeline Products 60
Table 37: Medtronic Coronary Stents Pipeline Products 61
Table 38: Current Drug-Eluting Stents Approved for Use in the US 62
Table 39: CYPHER Coronary Stent 62
Table 40: CYPHER (SIRIUS Pivotal Trial) 63
Table 41: CYPHER (RAVEL Supporting Trial) 64
Table 42: PROMUS Coronary Stent 65
Table 43: PROMUS (SPIRIT III Trial)) 66
Table 44: ENDEAVOR Coronary Stent 68
Table 45: ENDEAVOR (ENDEAVOR III Trial)) 68
Table 46: ENDEAVOR (ENDEAVOR IV Trial)) 70
Table 47: TAXUS Express2 (TAXUS IV Trial)) 72
Table 48: TAXUS Liberte (ATLAS Trial)) 74
Table 49: Biomatrix III (LEADER Trial) 80
Table 50: Biomatrix (STEALTH) 82
Table 51: NEVO Sirolimus-eluting coronary stent (RES-ELUTION II) 83
Table 52: NEVO Sirolimus-eluting coronary stent (RES-ELUTION I): Pivotal trial 85
Table 53: GTX Coronary Stent System 86
Table 54: ProGenic Pimecrolimus-eluting Coronary Stent System 87
Table 55: MAHOROBA 89
Table 56: ProLink LP 90
Table 57: ChromoFlex Coronary Stent 91
Table 58: ProNova Sirolimus Eluting Stent 92
Table 59: Coroflex DEBlue (PEPCADIIIsub) 93
Table 60: ENDEAVOR Resolute 94
Table 61: TAXUS Petal Bifurcation Paclitaxel-Eluting Stent System 97
Table 62: Coronary Stents : Pipeline Summary 99
Table 63: Coronary Stents Pipeline Products 106
Table 64: Coronary Stents Pipeline Products 107
Table 65: Coronary Stents Pipeline Products 107
Table 66: Coronary Stents Pipeline Products 108
Table 67: Coronary Stents Pipeline 109
Table 68: Coronary Stents Pipeline Products 109
Table 69: Coronary Stents: Key Acquisitions 110
1.2 List of Figures
Figure 1: Build up of Plaque in the Arteries 10
Figure 2: Atherosclerosis with Blood Clot and Arteries with Spasm 11
Figure 3: Signs and Symptoms of Coronary Heart Disease 12
Figure 4: Treatment Flow Model, Coronary Stents for Treatment of Coronary Heart Disease, US, 2009 14
Figure 5: Treatment Flow Model, Coronary Stents for Treatment of Coronary Heart Disease, Europe, 2009 14
Figure 6: Treatment Modalities for Coronary Heart Disease, 2009 16
Figure 7: Stent Procedure with Baloon Angioplasty 17
Figure 8: Coronary Stents Market, Global, Revenue ($bn), 2002 – 2009 18
Figure 9: Coronary Stents Market, Global, Revenue ($bn), 2009 – 2016 19
Figure 10: Drivers and Restraints in the Coronary Stents Market 20
Figure 11: US, Breakdown of Deaths from Cardiovascular Diseases, %,2006 20
Figure 12 Bare Metal Stents Market, Global, Revenue ($bn), 2002– 2009 24
Figure 13: Bare Metal Stents Market, Global, Revenue ($bn), 2009–2016 25
Figure 14: Drug Eluting Stents Market, Global, Revenue ($bn), 2002–2009 27
Figure 15: Drug Eluting Stents Market, Global, Revenue ($bn), 2009– 2016 28
Figure 16: Coronary Stents Market, Cross Country Analysis, Global, Revenue and growth Comparison 2002-2016 30
Figure 17: Coronary Stents Market, US, Revenue ($ m), 2002-2009 31
Figure 18: Coronary Stents Market, US, Revenue ($ m), 2009-2016 32
Figure 19: Coronary Stents Market, Canada, Revenue ($ m), 2002-2009 33
Figure 20: Coronary Stents Market, Canada, Revenue ($ m), 2009-2016 34
Figure 21: Coronary Stents Market, UK, Revenue ($ m), 2002-2009 35
Figure 22: Coronary Stents Market, UK, Revenue ($ m), 2009-2016 36
Figure 23: Coronary Stents Market, Italy, Revenue ($ m), 2002-2009 37
Figure 24: Coronary Stents Market, Italy, Revenue ($ m), 2009-2016 38
Figure 25: Coronary Stents Market, Germany, Revenue ($ m), 2002-2009 39
Figure 26: Coronary Stents Market, Germany, Revenue ($ m), 2009-2016 40
Figure 27: Coronary Stents Market, France, Revenue ($ m), 2002-2009 41
Figure 28: Coronary Stents Market, France, Revenue ($ m), 2009-2016 42
Figure 29: Coronary Stents Market, Spain, Revenue ($ m), 2002-2009 43
Figure 30: Coronary Stents Market, Spain, Revenue ($ m), 2009-2016 44
Figure 31: Coronary Stents Market, Japan, Revenue ($ m), 2002-2009 45
Figure 32: Coronary Stents Market, Japan, Revenue ($ m), 2009-2016 46
Figure 33: Coronary Stents Market,China, Revenue ($ m), 2002-2009 47
Figure 34: Coronary Stents Market, China, Revenue ($ m), 2009-2016 48
Figure 35: Coronary Stents Market, India, Revenue ($ m), 2002-2009 49
Figure 36: Coronary Stents Market, India, Revenue ($ m), 2009-2016 50
Figure 37: Coronary Stents Market, Brazil, Revenue ($ m), 2002-2009 51
Figure 38: Coronary Stents Market, Brazil, Revenue ($ m), 2009-2016 52
Figure 39: Coronary Stents Market, Australia, Revenue ($ m), 2002-2009 53
Figure 40: Coronary Stents Market, Australia, Revenue ($ m), 2009-2016 54
Figure 41: Drug Eluting Stents Market, Global, Company Share (% of Revenue), 2009 55
Figure 42: Bare Metal Stents Market, Global, Company Shares (% Revenue), 2009 56
Figure 43: Pipeline Technology Assessment for Coronary Stents by Development Stage, Global 76
Figure 44: Pipeline Technology Assessment for Drug Eluting and Bare Metal Stents By Development Stage, Global 77
Figure 45: Pipeline Technology Assessment for Drug Eluting Stents by Unmet Need, Global 78
Figure 46: Pipeline Technology Assessment for Bare Metal Stents by Unmet Need, Global 79
Figure 47: Key Acquisitions in 2009-2010 110
Figure 48: GlobalData Methodology 115
Companies mentioned
Biosensors International Group, Ltd.
Cook Medical Incorporated
OrbusNeich
Vascular Concepts Limited
CorNova, Inc.
Nexeon MedSystems, Inc.
To order this report:
Medical Devices Industry: Global Coronary Stents Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016
Check our Company Profile, SWOT and Revenue Analysis!
Contact
Nicolas Bombourg
Reportlinker
Email: [email protected]
US: (805)652-2626
Intl: +1 805-652-2626
SOURCE Reportlinker
Share this article